This page shows the latest Nestl Health Science news and features for those working in and with pharma, biotech and healthcare.
But evolutionary science doesn’t anticipate an easy future for firms that focus on their innovative businesses either. ... Nestl é Health Science and other companies.
Nestlé Health Science has taken a $145m stake in a US biotech whose lead product is a peanut allergy treatment that has Breakthrough Therapy Designation from the US FDA. . ... The deal will also see Nestlé Health Science's CEO Greg Behar take a seat
Acquisition of UK's Phagenesis expected to be completed by 2019. Nestlé Health Science is continuing to expand its interests in the broader pharma space with the acquisition of UK medical ... Greg Behar, chief executive at Nestlé Health Science, said:
More from news
Approximately 0 fully matching, plus 3 partially matching documents found.
Problem accessing /s/search.html. Reason:
Unable to parse URI query
OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...